Clincosm LogoSign in Get a demo

metastatic nsclc

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic NSCLC, Stage III NSCLC Trial (inupadenant, Placebo, Carboplatin)

Recruiting
  • Metastatic NSCLC
  • Stage III NSCLC
  • Fayetteville, Arkansas
  • +16 more
Jan 25, 2023

Non Small Cell Lung Cancer, Metastatic NSCLC, Recurrent Non Small Cell Lung Cancer Trial (Pembrolizumab, GT103)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +2 more
  • (no location specified)
Jan 12, 2023

Patients' Whole Process Follow-up Management

Recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • Metastatic NSCLC
  • Patients' whole process follow-up and management platform
  • Jinan, Shandong, China
    The First Affiliated Hospital of Shandong First Medical Universi
Sep 5, 2022

Metastatic NSCLC Trial in Montreal (Chinese herbs formula: Shu Yu Wan, Placebo capsules)

Withdrawn
  • Metastatic NSCLC
  • Chinese herbs formula: Shu Yu Wan
  • Placebo capsules
  • Montreal, Quebec, Canada
    Peter Brojge Lung Cancer Center, Jewish General Hospital
Aug 18, 2022

Solid Tumor, Adult, Metastatic Solid Tumor, Metastatic NSCLC Trial in Adelaide (BBP-398, sotorasib)

Recruiting
  • Solid Tumor, Adult
  • +3 more
  • Adelaide, South Australia, Australia
    Cancer Research SA
Aug 15, 2022

Metastatic NSCLC Trial in France (Pembrolizumab before randomization, Chemotherapy, Pemetrexed)

Recruiting
  • Metastatic NSCLC
  • Pembrolizumab before randomization
  • +3 more
  • Aix-en-Provence, France
  • +37 more
Jul 26, 2022

Metastatic NSCLC, Metastatic Head Neck Cancer Trial in Lyon, Pierre-Bénite (Blood draws)

Not yet recruiting
  • Metastatic NSCLC
  • Metastatic Head and Neck Cancer
  • Blood draws
  • Lyon, France
  • +1 more
Oct 20, 2021

Metastatic NSCLC, Recurrent NSCLC, Advanced Non-Small Cell Squamous Lung Cancer Trial in Nanjing (Sintilimab + Anlotinib +

Recruiting
  • Metastatic NSCLC
  • +2 more
  • Sintilimab + Anlotinib + Pemetrexed + Cisplatin or Carboplatin
  • Sintilimab + Anlotinib + Albumin Paclitaxel + Carboplatin
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Aug 10, 2021

Numerical Simulation Using Quantitative CT : the MEKANOS Study

Recruiting
  • Metastases to Bone
  • +2 more
  • Evaluation of the fracture risk using data from routine qCT (quantitative Computed Tomography) scan and numerical simulation
  • Angers, France
  • +10 more
Jul 26, 2021

NSCLC (NSCLC), Stage IV NSCLC, Metastatic NSCLC Trial in Birmingham, Atlanta (Cabazitaxel-XRP6258 (3-week cycle),

Completed
Has Results
  • Non-small Cell Lung Cancer (NSCLC)
  • +2 more
  • Cabazitaxel-XRP6258 (3-week cycle)
  • Cabazitaxel-XRP6258 (5-week cycle)
  • Birmingham, Alabama
  • +1 more
Apr 24, 2017